发明名称 Pyridine and pyrimidine based compounds as Wnt signaling pathway inhibitors for the treatment of cancer
摘要 The present invention relates to pyridine and pyrimidine based compounds, pharmaceutical compositions comprising these compounds and their potential use as therapeutic agents for the treatment and/or prevention of cancer.
申请公布号 US8778925(B2) 申请公布日期 2014.07.15
申请号 US200913122555 申请日期 2009.10.06
申请人 Cancer Research Technology Ltd. 发明人 McDonald Edward;Blagg Julian;Pichowicz Mark;Crumpler Simon Ross
分类号 A01N43/00;A61K31/00;A61K31/55;A01N43/42;A61K31/44;A01N43/38;A61K31/40;C07D225/04;C07D223/14;C07D487/00;C07D491/00;C07D513/00;C07D215/00;C07D217/00;C07D219/00;C07D221/00;C07D209/96;C07D495/00 主分类号 A01N43/00
代理机构 The Marbury Law Group, PLLC 代理人 The Marbury Law Group, PLLC
主权项 1. A compound of the formula (I):wherein W, X and Y are each independently CH, C(R4) or N; Z is C(R6); R1 and R2 are each independently hydrogen or C1-6 alkyl; or R1 and R2 taken together with the carbon atom to which they are attached may form a 5- or 6-membered carbocycle or heterocycle, either of which is optionally substituted with 1, 2, 3, 4 or 5 Ra; R3 and R4 are each independently halo or a group selected from C1-6 alkyl, C1-6 alkoxy, carbocyclyl and heterocyclyl, any of which is optionally substituted with 1, 2, 3, 4 or 5 Ra; wherein R5 and R6 taken together with the carbon atom to which they are attached form a 5- or 6-membered heterocycle containing a ring amide group, wherein the heterocycle is unsubstituted; each Ra is independently selected from halogen, trifluoromethyl, cyano, oxo, nitro, —ORb, —C(O)Rb, —C(O)ORb, —OC(O)Rb, —S(O)lRb, —N(Rb)Rc, —N(Rb)C(O)Rc, —C(O)N(Rb)Rc, —S(O)lN(Rb)Rc and Rd; Rb and Rc are each independently hydrogen or Rd; Rd is selected from hydrocarbyl (e.g. C1-6alkyl), carbocyclyl, carbocyclyl-C1-6alkyl, and heterocyclyl, each of which is optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected from halogen, cyano, amino, hydroxy, C1-6 alkyl, C1-6 alkoxy; l is 0, 1 or 2; and m and n are each independently 1, 2 or 3;or a pharmaceutically acceptable salt or N-oxide thereof.
地址 London GB